Grünenthal Group

- nopioids.net
Not Applicable $ 8.95


EFIC GRÜNENTHAL GRANT - EFIC GRUENENTHAL GRANT

- e-g-g.info

Bi-annual grants totalling up to Euro 200,000 from Grünenthal GmbH supporting young scientists in carrying out innovative and exploratory clinical pain research projects in any country with an EFIC chapter.

Not Applicable $ 8.95

Grünenthal Group

- grunenthal.info

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

2,323,979 $ 480.00

Grünenthal Group

- grunenthal-pro.info

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal Group

- grunenthal-pro.com

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal Pharma S.A.

- andromaco.biz

Grünenthal Pharma S.A.

Not Applicable $ 8.95

Grünenthal Portugal, S.A.

- eurolabor.biz

Grünenthal S.A. Portugal

Not Applicable $ 8.95

Grünenthal Portugal, S.A.

- euro-labor.biz

Grünenthal S.A. Portugal

Not Applicable $ 8.95

Grünenthal Group

- gruenenthal.biz
Not Applicable $ 8.95

Grünenthal Group

- grunenthal.biz
Not Applicable $ 8.95

Grünenthal Group

- grunenthalpharma.biz
Not Applicable $ 8.95

Grünenthal Group

- localpaintreatment.com

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal Group

- aminhador.com

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal Group

- iflocal-actlocal.com

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal Group

- intacformulation.com

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal Group

- abusedeterrenttechnology.com

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal Group

- grunenthalhealth.com

The Grünenthal Group is an independent, family-owned international research based pharmaceutical company headquartered in Aachen, Germany. Building on its unique position in pain, its objective is to become the most patient-centric company to be a leader in therapy innovation.

Not Applicable $ 8.95

Grünenthal GmbH - Schmerzbehandlung

- schulungsmaterial.grunenthal.de

Grünenthal ist ein unabhängiges, international tätiges, forschendes Pharmaunternehmen im Familienbesitz mit Konzernzentrale in Aachen, Deutschland. Aufbauend auf ihrer einmaligen Kompetenz in der Schmerzbehandlung ist es das Ziel, die patientenzentrierteste Firma und damit führend in Therapie-Innovation zu werden.

Not Applicable $ 8.95


Reporte de reacciones adversas

- drug-safety.grunenthal.com
1,824,206 $ 720.00